Institutional Ownership Inozyme Pharma, Inc. (INZY)
This table provides information about the institutional ownership of Inozyme Pharma, Inc. (INZY). We have compiled data on the 87 institutions that hold shares in the stock, with a total of 51.9 Million shares, which have been reported (via 13F filing form) to have a value of $208 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Beryl Capital Management LLC
Redondo Beach, CA |
Aug 14, 2025 Q2 2025 |
6,321,584
shares
|
$25.3 Million
3.83% of portfolio
|
Q2 2025
New holding
|
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
Aug 13, 2025 Q2 2025 |
4,494,851
shares
|
$18 Million
16.98% of portfolio
|
Q3 2023
Added 22.76%
|
|
Glazer Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
4,330,220
shares
|
$17.3 Million
0.62% of portfolio
|
Q2 2025
New holding
|
|
Sofinnova Investments, Inc.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
4,280,308
shares
|
$17.1 Million
1.16% of portfolio
|
Q4 2023
Added 17.1%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,343,193
shares
|
$13.4 Million
0.0% of portfolio
|
Q2 2024
Added 8.24%
|
|
Oddo Bhf Asset Management Sas
Paris, I0 |
Aug 14, 2025 Q2 2025 |
3,200,000
shares
|
$12.8 Million
0.5% of portfolio
|
Q2 2025
New holding
|
|
Trium Capital LLP
London, X0 |
Aug 11, 2025 Q2 2025 |
3,173,454
shares
|
$12.7 Million
1.53% of portfolio
|
Q2 2025
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,498,649
shares
|
$9.99 Million
0.0% of portfolio
|
Q2 2025
Reduced 9.42%
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
2,437,689
shares
|
$9.75 Million
0.81% of portfolio
|
Q4 2022
Reduced 0.27%
|
|
Alpine Associates Management Inc.
Englewood Cliffs, NJ |
Aug 05, 2025 Q2 2025 |
2,188,100
shares
|
$8.75 Million
0.48% of portfolio
|
Q2 2025
New holding
|
|
Affinity Asset Advisors, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
1,749,359
shares
|
$7 Million
1.17% of portfolio
|
Q2 2025
Reduced 54.77%
|
|
Gabelli Funds LLC
Rye, NY |
Aug 13, 2025 Q2 2025 |
1,457,800
shares
|
$5.83 Million
0.05% of portfolio
|
Q2 2025
New holding
|
|
Chi Advisors LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
1,270,027
shares
|
$5.08 Million
2.63% of portfolio
|
Q3 2023
Added 6.28%
|
|
Gardner Lewis Asset Management L P
Chadds Ford, PA |
Aug 12, 2025 Q2 2025 |
1,257,765
shares
|
$5.03 Million
1.27% of portfolio
|
Q2 2025
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,221,125
shares
|
$4.88 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.78%
|
|
Omers Administration Corp
Toronto, A6 |
Aug 13, 2025 Q2 2025 |
1,116,800
shares
|
$4.47 Million
0.04% of portfolio
|
Q2 2025
New holding
|
|
Man Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
670,155
shares
|
$2.68 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
Knott David M Jr
Syosset, NY |
Aug 11, 2025 Q2 2025 |
666,204
shares
|
$2.66 Million
1.69% of portfolio
|
Q1 2025
Reduced 4.14%
|
|
Gabelli & CO Investment Advisers, Inc.
Rye, NY |
Aug 13, 2025 Q2 2025 |
617,000
shares
|
$2.47 Million
0.42% of portfolio
|
Q2 2025
New holding
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
535,185
shares
|
$2.14 Million
0.01% of portfolio
|
Q2 2025
Reduced 46.68%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
481,799
shares
|
$1.93 Million
0.0% of portfolio
|
Q2 2025
Reduced 61.29%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
470,500
shares
|
$1.88 Million
0.0% of portfolio
|
Q2 2025
Reduced 16.65%
|
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
Aug 13, 2025 Q2 2025 |
377,227
shares
|
$1.51 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
331,772
shares
|
$1.33 Million
0.0% of portfolio
|
Q2 2025
Reduced 66.73%
|
|
Susquehanna Portfolio Strategies, LLC
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
260,713
shares
|
$1.04 Million
0.02% of portfolio
|
Q2 2025
New holding
|